Search

everythinglearnresearchcommunity

for

Search:↓

Deuruxolitinib significantly improves hair satisfaction in severe alopecia areata patients.

Both tofacitinib and ruxolitinib are effective and tolerable for treating alopecia areata.

Oral minoxidil can help regrow hair lost from antibody-drug conjugate treatment.

CAR-T therapy offers hope for children with hard-to-treat blood cancers.

Tofacitinib effectively treated both ulcerative colitis and alopecia areata in two patients.

The study created special nanoparticles that effectively deliver an anti-inflammatory drug to treat skin inflammation in psoriasis.

A 15-year-old boy's severe scalp condition improved significantly with adalimumab and baricitinib treatment.

Methotrexate is not proven to maintain remission in ulcerative colitis.

Ritlecitinib is being tested for effectiveness and safety in treating severe alopecia areata.

Tofacitinib may be effective for treating hair loss caused by alopecia areata that doesn't respond to other treatments.

Leflunomide and methotrexate are equally effective for rheumatoid arthritis but have different side effects.

Oral tofacitinib shows promise in treating atopic dermatitis and alopecia areata, but only slight improvement in vitiligo.

Abrocitinib, a JAK inhibitor, may help treat atopic dermatitis and alopecia universalis together.

Immunotherapy with pembrolizumab significantly reduced cancer in a young woman with adrenocortical carcinoma.

Ritlecitinib is effective long-term for treating alopecia areata in teens.

Rezpegaldesleukin shows promise for treating severe alopecia areata.

Ritlecitinib may cause serious side effects like blood clots in alopecia areata patients.

Combining Western chemotherapy with Traditional Chinese Medicine can reduce side effects and improve immune response in treating bone and soft tissue tumors.

Oral ritlecitinib and baricitinib are promising treatments for severe alopecia areata due to their balance of effectiveness and safety.

Enhancing Tregs can protect against alopecia areata.

Ritlecitinib improves hair regrowth in alopecia areata without increasing adverse risks.

Tofacitinib helped a patient regrow hair after 40 years of total hair loss.

Two drugs, ritlecitinib and brepocitinib, improved scalp hair loss condition markers.

Tofacitinib helped regrow hair in a lupus patient with alopecia.

Reticular erythematous mucinosis syndrome can occur with minimal mucin deposition.

Infliximab can cause SAPHO syndrome, which may improve with Spesolimab and methotrexate.

Nemolizumab improved both severe atopic dermatitis and alopecia areata in one patient.

Tofacitinib helped improve symptoms and hair growth in a patient with Aicardi-Goutières syndrome.

Ritlecitinib is effective and safe for hair regrowth in Asian patients with alopecia areata.